Literature DB >> 29222328

Fructose and glucose can regulate mammalian target of rapamycin complex 1 and lipogenic gene expression via distinct pathways.

Yue Hu1, Ivana Semova1, Xiaowei Sun1, Hong Kang1, Satyapal Chahar1, Anthony N Hollenberg2, David Masson3, Matthew D Hirschey4, Ji Miao5, Sudha B Biddinger6.   

Abstract

Although calorically equivalent to glucose, fructose appears to be more lipogenic, promoting dyslipidemia, fatty liver disease, cardiovascular disease, and diabetes. To better understand how fructose induces lipogenesis, we compared the effects of fructose and glucose on mammalian target of rapamycin complex 1 (mTORC1), which appeared to have both positive and negative effects on lipogenic gene expression. We found that fructose acutely and transiently suppressed mTORC1 signaling in vitro and in vivo The constitutive activation of mTORC1 reduced hepatic lipogenic gene expression and produced hypotriglyceridemia after 1 week of fructose feeding. In contrast, glucose did not suppress mTORC1, and the constitutive activation of mTORC1 failed to suppress plasma triglycerides after 1 week of glucose feeding. Thus, these data reveal fundamental differences in the signaling pathways used by fructose and glucose to regulate lipid metabolism.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  dyslipidemia; fructose; glucose; lipogenesis; mammalian target of rapamycin (mTOR); metabolic syndrome

Mesh:

Substances:

Year:  2017        PMID: 29222328      PMCID: PMC5808762          DOI: 10.1074/jbc.M117.782557

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.

Authors:  Yonghao Yu; Sang-Oh Yoon; George Poulogiannis; Qian Yang; Xiaoju Max Ma; Judit Villén; Neil Kubica; Gregory R Hoffman; Lewis C Cantley; Steven P Gygi; John Blenis
Journal:  Science       Date:  2011-06-10       Impact factor: 47.728

2.  Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.

Authors:  Jessica L Yecies; Hui H Zhang; Suchithra Menon; Sihao Liu; Derek Yecies; Alex I Lipovsky; Cem Gorgun; David J Kwiatkowski; Gökhan S Hotamisligil; Chih-Hao Lee; Brendan D Manning
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

3.  Functional roles of fructose.

Authors:  Jinyoung Kim; Gwonhwa Song; Guoyao Wu; Fuller W Bazer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-23       Impact factor: 11.205

4.  Transcriptional control of cellular metabolism by mTOR signaling.

Authors:  Jessica L Yecies; Brendan D Manning
Journal:  Cancer Res       Date:  2011-04-12       Impact factor: 12.701

5.  Restoration of autophagy alleviates hepatic ER stress and impaired insulin signalling transduction in high fructose-fed male mice.

Authors:  Hao Wang; Ruo-Qiong Sun; Xiao-Yi Zeng; Xiu Zhou; Songpei Li; Eunjung Jo; Juan C Molero; Ji-Ming Ye
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

6.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

7.  Sterol regulatory element-binding protein-1 is regulated by glucose at the transcriptional level.

Authors:  A H Hasty; H Shimano; N Yahagi; M Amemiya-Kudo; S Perrey; T Yoshikawa; J Osuga; H Okazaki; Y Tamura; Y Iizuka; F Shionoiri; K Ohashi; K Harada; T Gotoda; R Nagai; S Ishibashi; N Yamada
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

Review 8.  Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.

Authors:  Richard J Johnson; Mark S Segal; Yuri Sautin; Takahiko Nakagawa; Daniel I Feig; Duk-Hee Kang; Michael S Gersch; Steven Benner; Laura G Sánchez-Lozada
Journal:  Am J Clin Nutr       Date:  2007-10       Impact factor: 7.045

9.  Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms.

Authors:  Makoto Miyazaki; Agnieszka Dobrzyn; Weng Chi Man; Kiki Chu; Harini Sampath; Hyoun-Ju Kim; James M Ntambi
Journal:  J Biol Chem       Date:  2004-04-05       Impact factor: 5.157

10.  SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth.

Authors:  Thomas Porstmann; Claudio R Santos; Beatrice Griffiths; Megan Cully; Mary Wu; Sally Leevers; John R Griffiths; Yuen-Li Chung; Almut Schulze
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

View more
  6 in total

1.  SREBP-regulated adipocyte lipogenesis is dependent on substrate availability and redox modulation of mTORC1.

Authors:  Clair Crewe; Yi Zhu; Vivian A Paschoal; Nolwenn Joffin; Alexandra L Ghaben; Ruth Gordillo; Da Young Oh; Guosheng Liang; Jay D Horton; Philipp E Scherer
Journal:  JCI Insight       Date:  2019-07-16

Review 2.  Molecular aspects of fructose metabolism and metabolic disease.

Authors:  Mark A Herman; Morris J Birnbaum
Journal:  Cell Metab       Date:  2021-10-06       Impact factor: 27.287

3.  Convergence of Fructose-Induced NLRP3 Activation with Oxidative Stress and ER Stress Leading to Hepatic Steatosis.

Authors:  Sushmita Singh; Aditya Sharma; Shadab Ahmad; Bhavimani Guru; Farah Gulzar; Pawan Kumar; Ishbal Ahmad; Akhilesh K Tamrakar
Journal:  Inflammation       Date:  2022-08-09       Impact factor: 4.657

Review 4.  mTOR is a Key Protein Involved in the Metabolic Effects of Simple Sugars.

Authors:  Gemma Sangüesa; Núria Roglans; Miguel Baena; Ana Magdalena Velázquez; Juan Carlos Laguna; Marta Alegret
Journal:  Int J Mol Sci       Date:  2019-03-05       Impact factor: 5.923

5.  DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1.

Authors:  Xin Tong; Deqiang Zhang; Omar Shabandri; Joon Oh; Ethan Jin; Kenneth Stamper; Meichan Yang; Zifeng Zhao; Lei Yin
Journal:  Metabolism       Date:  2020-04-01       Impact factor: 8.694

Review 6.  Pathological Consequences of Hepatic mTORC1 Dysregulation.

Authors:  Chun-Seok Cho; Allison Ho Kowalsky; Jun Hee Lee
Journal:  Genes (Basel)       Date:  2020-08-05       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.